NPR Notícias de negócios: Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19
The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.

leia mais em NPR